Abstract
Objective
To assess the effect of high-dose vitamin D in patients with painful diabetic neuropathy.


Methods
A single intramuscular dose of 600 000 IU vitamin D was administered, and the effects on metabolic parameters and neuropathic pain assessed over 20 weeks.


Results
143 participants with predominantly type 2 diabetes, aged 52.31±11.48 years, with a Douleur Neuropathique 4 (DN4) score (3.0±1.8), total McGill pain score (21.2±14.9), and Short Form McGill Pain Questionnaire (SFMPQ) score (2.1±0.9), were enrolled. The baseline 25-hydroxyvitamin D (25(OH)D) level was 31.7±23.3 ng/mL and 58 (40.5%) patients showed evidence of vitamin D deficiency (25(OH)D<20 ng/mL). Intramuscular administration of vitamin D resulted in a significant increase in 25(OH)D (46.2±10.2 ng/mL, p<0.0001) and a reduction in positive symptoms on the DN4 (p<0.0001), total pain score (p<0.0001), and SFMPQ (p<0.0001).


Conclusions
Treatment with a single intramuscular dose of 600 000 IU of vitamin D in patients with painful diabetic neuropathy is associated with a significant decrease in the symptoms of painful diabetic neuropathy.


Trial registration number
BIDE-12/2014.
Topics

No keywords indexed for this article. Browse by subject →

References
41
[3]
Sadosky "Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey" Diabetes Metab Syndr Obes (2013) 10.2147/dmso.s37415
[12]
Alamdari "An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects" Neurol Sci (2015) 10.1007/s10072-015-2207-0
[13]
Maser "Vitamin D insufficiency is associated with reduced parasympathetic nerve fiber function in type 2 diabetes" Endocr Pract (2015) 10.4158/ep14332.or
[14]
Lv "Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis" J Endocrinol Invest (2015) 10.1007/s40618-014-0210-6
[15]
Celikbilek "Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey" Acta Neurol Belg (2015) 10.1007/s13760-014-0304-0
[25]
Vitamin D as an Analgesic for Patients With Type 2 Diabetes and Neuropathic Pain

Paul Lee

Archives of Internal Medicine 10.1001/archinte.168.7.771
[26]
Prospective Evaluation of the Effect of Short-Term Oral Vitamin D Supplementation on Peripheral Neuropathy in Type 2 Diabetes Mellitus

D. Shehab, Khaled Al-Jarallah, Nabila Abdella et al.

Medical Principles and Practice 2015 10.1159/000375304
[30]
Iqbal "Illuminating the dark side—vitamin D status in different localities of Karachi" J Coll Physicians Surg Pak (2013)
[31]
Khan "Prevalence of vitamin D deficiency and its correlates: results of a community-based study conducted in Karachi, Pakistan" Arch Osteoporos (2012) 10.1007/s11657-012-0108-x
[32]
Mansoor "Prevalence and significance of vitamin D deficiency and insufficiency among apparently healthy adults" Clin Biochem (2010) 10.1016/j.clinbiochem.2010.09.022
[33]
Shaheen "Serum alkaline phosphatase screening for vitamin D deficiency states" J Coll Physicians Surg Pak (2012)
[34]
Sheikh "Vitamin D levels in asymptomatic adults—a population survey in Karachi, Pakistan" PLoS ONE (2012) 10.1371/journal.pone.0033452
[36]
Valensi "A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report" J Diabetes Complications (2005) 10.1016/j.jdiacomp.2005.05.011
[37]
Bell "Reversal of the symptoms of diabetic neuropathy through correction of vitamin D deficiency in a type 1 diabetic patient" Case Rep Endocrinol (2012)